Adam Maeder
Stock Analyst at Piper Sandler
(3.80)
# 676
Out of 4,910 analysts
89
Total ratings
52.54%
Success rate
9.32%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintains: Neutral | $18 → $10 | $8.00 | +25.00% | 2 | Jul 9, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.5 → $4 | $3.70 | +8.11% | 1 | Jun 18, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $80 → $83 | $77.03 | +7.75% | 15 | May 13, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $2.46 | +62.60% | 4 | May 12, 2025 | |
| TCMD Tactile Systems Technology | Downgrades: Neutral | $25 → $14 | $10.22 | +36.99% | 3 | May 6, 2025 | |
| RMD ResMed | Maintains: Neutral | $260 → $248 | $270.53 | -8.33% | 3 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $670 → $575 | $495.80 | +15.97% | 19 | Apr 23, 2025 | |
| ABT Abbott Laboratories | Reiterates: Overweight | $133 → $145 | $124.35 | +16.61% | 3 | Apr 17, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $11 → $8.5 | $12.12 | -29.84% | 7 | Mar 18, 2025 | |
| INSP Inspire Medical Systems | Maintains: Overweight | $260 → $233 | $130.73 | +78.23% | 14 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $12.80 | +64.06% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $4.41 | +81.41% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $7.84 | +155.10% | 8 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.24 | +123.21% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $2.49 | +622.89% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $43.79 | +126.08% | 3 | May 5, 2022 |
RxSight
Jul 9, 2025
Maintains: Neutral
Price Target: $18 → $10
Current: $8.00
Upside: +25.00%
Sight Sciences
Jun 18, 2025
Maintains: Neutral
Price Target: $3.5 → $4
Current: $3.70
Upside: +8.11%
Edwards Lifesciences
May 13, 2025
Maintains: Overweight
Price Target: $80 → $83
Current: $77.03
Upside: +7.75%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $2.46
Upside: +62.60%
Tactile Systems Technology
May 6, 2025
Downgrades: Neutral
Price Target: $25 → $14
Current: $10.22
Upside: +36.99%
ResMed
Apr 24, 2025
Maintains: Neutral
Price Target: $260 → $248
Current: $270.53
Upside: -8.33%
Intuitive Surgical
Apr 23, 2025
Maintains: Overweight
Price Target: $670 → $575
Current: $495.80
Upside: +15.97%
Abbott Laboratories
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $124.35
Upside: +16.61%
Vicarious Surgical
Mar 18, 2025
Maintains: Neutral
Price Target: $11 → $8.5
Current: $12.12
Upside: -29.84%
Inspire Medical Systems
Feb 10, 2025
Maintains: Overweight
Price Target: $260 → $233
Current: $130.73
Upside: +78.23%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $12.80
Upside: +64.06%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $4.41
Upside: +81.41%
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $7.84
Upside: +155.10%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.24
Upside: +123.21%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $2.49
Upside: +622.89%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $43.79
Upside: +126.08%